FI114010B - Menetelmä kasvainsairauksien parantamiseen tarkoitettujen farmaseuttisten tuotteiden valmistamiseksi - Google Patents

Menetelmä kasvainsairauksien parantamiseen tarkoitettujen farmaseuttisten tuotteiden valmistamiseksi Download PDF

Info

Publication number
FI114010B
FI114010B FI941979A FI941979A FI114010B FI 114010 B FI114010 B FI 114010B FI 941979 A FI941979 A FI 941979A FI 941979 A FI941979 A FI 941979A FI 114010 B FI114010 B FI 114010B
Authority
FI
Finland
Prior art keywords
deuterium
ppm
water
tumor
treatment
Prior art date
Application number
FI941979A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI941979A0 (fi
FI941979A (fi
Inventor
Gabor Somlyai
Original Assignee
Hyd Kutato Fejlesztoe Kft
Gabor Somlyai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyd Kutato Fejlesztoe Kft, Gabor Somlyai filed Critical Hyd Kutato Fejlesztoe Kft
Publication of FI941979A0 publication Critical patent/FI941979A0/fi
Publication of FI941979A publication Critical patent/FI941979A/fi
Application granted granted Critical
Publication of FI114010B publication Critical patent/FI114010B/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI941979A 1991-10-31 1994-04-29 Menetelmä kasvainsairauksien parantamiseen tarkoitettujen farmaseuttisten tuotteiden valmistamiseksi FI114010B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
HU343791 1991-10-31
HU913437A HU208084B (en) 1991-10-31 1991-10-31 Process for producing compositions suitable for curing tumorous diseases
HU9200036 1992-09-28
PCT/HU1992/000036 WO1993008794A1 (en) 1991-10-31 1992-09-28 Pharmaceutical products for curing tumorous diseases and process for preparing same

Publications (3)

Publication Number Publication Date
FI941979A0 FI941979A0 (fi) 1994-04-29
FI941979A FI941979A (fi) 1994-06-29
FI114010B true FI114010B (fi) 2004-07-30

Family

ID=10964023

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941979A FI114010B (fi) 1991-10-31 1994-04-29 Menetelmä kasvainsairauksien parantamiseen tarkoitettujen farmaseuttisten tuotteiden valmistamiseksi

Country Status (22)

Country Link
US (1) US5855921A (de)
JP (1) JP3569916B2 (de)
KR (1) KR100253874B1 (de)
CN (1) CN1045162C (de)
AT (1) AT402692B (de)
BE (1) BE1006186A3 (de)
CA (1) CA2122612C (de)
CH (1) CH685282A5 (de)
CZ (1) CZ282379B6 (de)
DE (1) DE4232465B4 (de)
DK (1) DK170832B1 (de)
ES (1) ES2077530B1 (de)
FI (1) FI114010B (de)
FR (1) FR2683148B1 (de)
GB (1) GB2276086B (de)
HU (1) HU208084B (de)
IT (1) IT1255390B (de)
LU (1) LU88175A1 (de)
NL (1) NL194664C (de)
NO (1) NO307031B1 (de)
SE (1) SE513624C2 (de)
WO (1) WO1993008794A1 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69428213T2 (de) * 1994-01-06 2002-06-13 Hyd Kutato-Fejleszto Ktf, Budapest Nahrungsmittel zur verhinderung der entwicklung von erkrankungen und verfahren zur herstellung dieser nahrungsmittel
HU214824B (hu) * 1994-03-23 1998-06-29 HYD Kutató-Fejlesztő Kft. Bőrbetegségek kezelésére és megelőzésére alkalmas kozmetikai, higiéniai, valamint szépség- és testápolási készítmények és eljárás azok előállítására
DE4427690A1 (de) * 1994-08-04 1996-02-08 Bogdahn Ulrich Prof Deuterium enthaltende pharmazeutische Zusammensetzung als Zytostatikum oder Tumor-Therapeutikum
HU217418B (hu) * 1995-04-20 2000-01-28 László Kótai Kémiai eljárás alacsony deutériumtartalmú víz előállítására
RU2083210C1 (ru) * 1995-09-13 1997-07-10 Николаева Ирина Сергеевна Средство для профилактической, поддерживающей и восстановительной терапии развивающихся при старении и/или под воздействием патогенных факторов патологий, связанных с дистрофическим и дегенеративными изменениями органов и тканей
US6444238B1 (en) 2000-03-10 2002-09-03 General Cosmetics Corporation Pain relief composition and method of relieving pain
HU226984B1 (en) * 2001-12-12 2010-04-28 Hyd Kutato Fejlesztoe Kft Medical and food products for treating diabetes mellitus and process for producing thereof
JP2005517904A (ja) * 2002-02-12 2005-06-16 ザ リージェント オブ ザ ユニバーシティ オブ カリフォルニア 標識取り込みにより生物学的分子の生合成の割合を測定する非侵襲性の方法
US20060094057A1 (en) 2002-07-30 2006-05-04 Maro K. Hellerstein Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry
WO2004022098A1 (en) * 2002-09-09 2004-03-18 Borsos Ferenc Oxygen-enriched water, treated within a magnetic field and heavy water
CA2498378C (en) * 2002-09-13 2013-12-17 The Regents Of The University Of California Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis
CA2504313C (en) 2002-11-04 2012-01-17 Marc K. Hellerstein Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body
JP2004315487A (ja) * 2003-04-17 2004-11-11 Internatl Scient:Kk 重水素減少水(スーパーライトウォーター)を原料とするスポーツドリンクの飲用による筋肉増強、及び製造方法。
RO120171B1 (ro) * 2003-05-23 2005-10-28 Ioan Nedelcu Produse cosmetice şi pentru igienă, procedeu de obţinere şi procedeu de aplicare a acestora
US7262020B2 (en) * 2003-07-03 2007-08-28 The Regents Of The University Of California Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
RO120505B1 (ro) * 2003-08-13 2006-02-28 Institutul Oncologic Profesor Dr. Al. Trestioreanu Metodă pentru stabilirea in vivo la animale de experienţă, a concentraţiei eficiente de apă sărăcită în deuteriu pentru tratamentul cancerului
US20050202406A1 (en) 2003-11-25 2005-09-15 The Regents Of The University Of California Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
WO2005070438A1 (en) * 2004-01-23 2005-08-04 Igor Anatolievich Pomytkin Pharmaceutical composition comprising water depleted of heavy isotopes 0-17 and 0-18
TW200538738A (en) 2004-02-20 2005-12-01 Univ California Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
US20050226825A1 (en) * 2004-04-13 2005-10-13 Giampapa Vincent C Topical composition for preventing and treating skin damage caused by UV light exposure
WO2005117566A1 (ja) * 2004-06-03 2005-12-15 Kunihiro Seki 低重水素濃度食品の生産装置
RO121676B1 (ro) * 2004-08-18 2008-02-28 Institutul Oncologic "Prof.Dr. Al. Trestioreanu" Metodă de creştere a toleranţei organismului la tratamentul cu citostatice
BRPI0520020A2 (pt) * 2005-02-08 2009-04-14 Woodford Associates Ltd bebidas alccoólicas enriquecidas com 1h2 16o
RS20070331A (en) * 2005-02-08 2009-03-25 Woodford Asociates Ltd., Non-alcoholic beverage enriched with 1h216o
US20080138439A1 (en) * 2005-03-05 2008-06-12 Sergey Pavlovich Soloviev Cosmetic Composition Enriched With 1H216O
US20080160102A1 (en) * 2005-03-11 2008-07-03 Igor Anatolievich Pomytkin Compositions For Disfecing Inanimate Surfaces
EA012855B1 (ru) * 2005-03-11 2009-12-30 Вада Консалтинг Лимитед Легкая фармацевтическая вода, терапевтические композиции, ее содержащие, способы их производства и применения
JP2008533005A (ja) * 2005-03-11 2008-08-21 ヴァーダ コンサルティング リミテッド 生物学的活性物質の皮内的、経皮的又は経粘膜的送達のための方法
RU2275920C1 (ru) * 2005-04-01 2006-05-10 Игорь Анатольевич Помыткин Способ лечения новообразований
US20060251576A1 (en) * 2005-05-03 2006-11-09 The Regents Of The University Of California Methods for measuring cholesterol metabolism and transport
TW200711660A (en) * 2005-06-10 2007-04-01 Univ California Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development
WO2007069933A1 (en) * 2005-12-12 2007-06-21 Vada Consulting Limited Method for decreasing postprandial glucose excursion
EA014536B1 (ru) * 2005-12-12 2010-12-30 Тимантти Аб Способ лечения метаболического синдрома
WO2007069932A1 (en) * 2005-12-12 2007-06-21 Vada Consulting Limited Method for suppressing appetite and food intake
HUP0900231A2 (hu) * 2009-04-16 2010-11-29 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Allergiás betegségek kezelésére, gyógyítására alkalmas készítmények és eljárás azok elõállítására
DE202009018629U1 (de) 2009-04-21 2012-06-11 Renate Rohlf Gesundheitsförderndes flüssiges Nahrungsmittel
US8658236B2 (en) * 2009-08-21 2014-02-25 Deuteria Beverages, Llc Alcoholic compositions having a lowered risk of acetaldehydemia
US20130129671A1 (en) * 2011-05-27 2013-05-23 Bristol-Myers Squibb Company Tripeptides Incorporating Deuterium as Inhibitors of Hepatitis C Virus
HUP1100290A2 (en) * 2011-06-01 2012-12-28 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Combination compositions for the treatment of proliferative diseases
EP2753707A4 (de) 2011-09-08 2015-03-04 Univ California Metabolische flussmessung, abbildung und mikroskopie
EP2788772B1 (de) 2011-12-07 2018-02-14 GlaxoSmithKline LLC Verfahren zur bestimmung der gesamtkörperskelettmuskelmasse
HUP1200552A2 (en) 2012-09-21 2014-04-28 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Pharmaceutical compositions for the treatment of high blood pressure
US20150313266A1 (en) * 2012-12-03 2015-11-05 Igor Anatolievich Pomytkin Food for the dietary management of burnout
US9134319B2 (en) 2013-03-15 2015-09-15 The Regents Of The University Of California Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo
CN103462830A (zh) * 2013-09-03 2013-12-25 大连世纪新源技术开发有限公司 超轻水多肽化妆品及其制备方法
US20150374745A1 (en) * 2014-06-30 2015-12-31 Mitochondrial Substrate Invention Limited Nutrients solutions for enhancement of cognitive function
RU2601046C1 (ru) * 2015-07-29 2016-10-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный университет" (ФГБОУ ВПО "КубГУ") Способ снижения содержания дейтерия в пищевых сельскохозяйственных культурах
AU2017329108B2 (en) * 2016-09-21 2022-07-07 Botanical Water Technologies Ip Ltd Isotopic compositions
US20200368686A1 (en) 2018-01-02 2020-11-26 Botanical Water Technologies Ip Ltd Isotopic compositions ii
WO2019174659A1 (de) 2018-03-15 2019-09-19 Karl Bau Gmbh Verfahren und anordnung zur herstellung von deuterium reduziertem wasser
CN112811559A (zh) * 2020-12-30 2021-05-18 江苏奥特泉超轻水饮料有限公司 一种低氘氢水及其制备方法及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3807960A (en) * 1969-08-04 1974-04-30 V Thayer Apparatus for enrichment of deuterium between water and hydrogen sulfide by countercurrent mass transfer
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS56141822A (en) * 1980-04-07 1981-11-05 Hitachi Ltd Method for separating and recovering hydrogen isomer
US4411798A (en) * 1980-05-27 1983-10-25 Standard Oil Company Process for separating D2 O from H2 O using surfactant systems
FR2552324B1 (fr) * 1983-09-23 1985-11-22 Ionescu Pantelimon Dumitru Eau anticancereuse, procede pour sa realisation, outillage pour sa conservation, et methode pour le traitement du cancer
US4874780A (en) * 1987-03-11 1989-10-17 Norsk Hydro A.S. Anticancer compounds
DE3717883A1 (de) * 1987-05-27 1988-12-15 Schiwa Gmbh Verfahren und anordnung zur herstellung von physiologischen loesungen
EP0335918A1 (de) * 1987-08-07 1989-10-11 Mallinckrodt Diagnostica (Holland) B.V. Radiotherapeutische oder diagnostische zusammensetzung, enthaltend eine wasserstoffhaltige verbindung
IL85312A (en) * 1988-02-03 1991-08-16 Israel State Injectable pharmaceutical compositions having improved stability
US4931154A (en) * 1989-07-17 1990-06-05 Southwestern Analytical Chemicals, Inc. Production of metal borohydrides and organic onium borohydrides
US5223269A (en) * 1989-08-31 1993-06-29 Andrejs Liepins Methods and composition for the treatment of hypertension

Also Published As

Publication number Publication date
AT402692B (de) 1997-07-25
ITMI922233A1 (it) 1994-03-28
DE4232465A1 (de) 1993-05-06
KR930007461A (ko) 1993-05-20
CA2122612A1 (en) 1993-05-13
CA2122612C (en) 2003-02-04
KR100253874B1 (ko) 2000-04-15
LU88175A1 (fr) 1993-03-15
NL194664C (nl) 2002-11-04
ITMI922233A0 (it) 1992-09-28
WO1993008794A1 (en) 1993-05-13
CN1045162C (zh) 1999-09-22
DK170832B1 (da) 1996-02-05
BE1006186A3 (fr) 1994-06-07
CZ282379B6 (cs) 1997-07-16
GB9408654D0 (en) 1994-07-20
CH685282A5 (de) 1995-05-31
FI941979A0 (fi) 1994-04-29
ES2077530A1 (es) 1995-11-16
US5855921A (en) 1999-01-05
FR2683148A1 (fr) 1993-05-07
NO307031B1 (no) 2000-01-31
NO941590D0 (de) 1994-04-29
SE9401406L (sv) 1994-06-07
FI941979A (fi) 1994-06-29
JPH08501275A (ja) 1996-02-13
CN1071836A (zh) 1993-05-12
NL9220026A (nl) 1994-09-01
HU208084B (en) 1993-08-30
NL194664B (nl) 2002-07-01
HU913437D0 (en) 1992-01-28
GB2276086A (en) 1994-09-21
FR2683148B1 (fr) 1994-09-09
ES2077530B1 (es) 1996-07-01
GB2276086B (en) 1995-09-27
IT1255390B (it) 1995-10-31
DE4232465B4 (de) 2008-11-06
ATA902992A (de) 1996-12-15
SE9401406D0 (sv) 1994-04-25
JP3569916B2 (ja) 2004-09-29
NO941590L (de) 1994-06-23
SE513624C2 (sv) 2000-10-09
CZ102094A3 (en) 1994-12-15

Similar Documents

Publication Publication Date Title
FI114010B (fi) Menetelmä kasvainsairauksien parantamiseen tarkoitettujen farmaseuttisten tuotteiden valmistamiseksi
CN101076253A (zh) 宿醉治疗和减轻酒精的组合物
EP0279984B1 (de) Gebrauch von Gramineenextrakten als Arzneimittel
KR20050109269A (ko) 식초를 이용한 인삼 제제 및 이의 제조방법
JP2009286746A (ja) 冬虫夏草菌セミタケを含む外用剤
EP3313448B1 (de) Hochkonzentrierter meerwasser-mineralienextrakt und dessen verwendung
KR102161179B1 (ko) 홍차줄기 추출물을 함유하는 항산화성 조성물
EP2033650A1 (de) Hemmer der expression des nuklearen transkriptionsfaktors ap-1 sowie pharmazeutisches produkt mit dem hemmer
KR20200043852A (ko) 아젤라익산을 유효성분으로 함유하는 근력강화, 근육증강, 근육분화, 근육재생, 근감소증 억제효과를 갖는 조성물
KR101522596B1 (ko) 땅꽈리 추출물을 포함하는 혈관내피세포 노화로 유발되는 질병의 예방 또는 치료용 약학적 조성물
CN114729335A (zh) 多不饱和脂肪酸的单羟基或二羟基衍生物、其制备方法及其用途
WO2014045072A2 (en) Pharmaceutical compositions for the treatment of hypertension
KR101483587B1 (ko) 땅꽈리 추출물을 포함하는 세포노화 억제용 조성물
KR101782962B1 (ko) 백혈병 치료용 조성물 및 몰약 추출물의 제조방법
MXPA96003241A (en) Pharmaceutical products to cure tumor diseases and procedure for its preparation
KR20080022315A (ko) 미백활성 및 항염활성을 나타내는 비룡추출물
JPH08205819A (ja) 保健用飲食品
US20040028760A1 (en) Method of treating inflammation and inflammation-related pain
KR20040031800A (ko) 반도심층수 농축물을 함유한 항균 또는 살균 활성을 갖는약학조성물
KR100852417B1 (ko) 항산화 활성을 갖는 클로로젠티실 알코올 화합물을함유하는 조성물
JP2784626B2 (ja) 健康飲料
KR101472006B1 (ko) 수리취 추출물을 포함하는 세포노화 억제용 조성물
EP0914091B1 (de) Ethen enthaltende lösungen sowie deren verwendung in heil- und vorbeugeverfahren
CN114796113A (zh) 一种艾纳香油纳米乳剂在制备抗肿瘤药物及创伤修复药物中的应用
KR20150081701A (ko) 홍차줄기 추출물을 함유하는 항산화성 조성물

Legal Events

Date Code Title Description
MA Patent expired